Janux Therapeutics Inc - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Trump administration loses Alaska Senate ballot case as judge rejects election delay

Whitehaven Coal’s A$1bn Winchester South project clears major court hurdle but approvals remain outstanding

Sun Pharmaceutical (SUNPHARMA) gains US approval for ILUMYA as Q2 profit falls 36%

Macmahon completes A$75m Aspect Engineering acquisition with 6.2% earnings accretion forecast

Read More

Pharma Industry News

How next-generation masking strategies could reshape PSMA-directed T cell engager development

How Janux Therapeutics is advancing masked T cell engagers with JANX014. Find out what this means for prostate cancer treatment and immunotherapy.

bySoujanya Ravi

April 19, 2026

web analytics